South Korea’s GI Innovation Inc. announced its IPO on the Kosdaq market with plans to raise up to $34 million in March 2023. Funds raised from the IPO will go toward phase I/II clinical trials of ...
GI Innovation said on the 3rd that it will present on an immuno-oncology drug at the American Society of Clinical Oncology (ASCO). It is a venue for sharing the latest clinical information on oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results